We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
AusPAR: Crizanlizumab
Australian Public Assessment Report
Device/Product Name
Adakveo
Active ingredients
Crizanlizumab
AusPAR Date
Published
Submission Number
PM-2019-05705-1-6
Submission Type
New biological entity
Decision
Approved